MedTrace Logo

Comparison of Bioimpedance Body Composition Device Measurements

NCT01888068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-08-01

No results posted yet for this study

Summary

A new investigational device (BIA/Vitality Analyzer™) is being compared to a United States Food and Drug Approved 'predicate' reference device (EFG®) to demonstrate that they provide equivalent measurements of body fat. Both devices are "over-the-counter" bioimpedance body composition analyzers (estimate of body fat). These devices are classified as 'Not Significant Risk' devices; they do not expose you to any significant risks.

Conditions

  • Self-declared Healthy Subjects

Sponsors & Collaborators

  • IPGDx, LLC

    lead INDUSTRY

Principal Investigators

  • Hank C Lukaski, PhD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01888068 on ClinicalTrials.gov